p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes
Cells · 18.08.2025 · 14 (16) · 1277
DOI: 10.3390/cells14161277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 18.08.2025. Verfasst von Eyal Bengal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, The Ruth and Bruce Rappaport Faculty of Medicine, P.O. Box 9649, Bat Galim, Haifa 31096, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Muscle, Skeletal, Energy Metabolism, Mitogen-Activated Protein Kinase 14. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rappaport Family Institute for Research in the Medical Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D), a growing global health concern, is closely linked to obesity and sedentary behavior. Central to its development are insulin resistance and impaired glucose metabolism in peripheral tissues, particularly skeletal muscle, which plays a key role in energy expenditure, glucose uptake, and insulin sensitivity. Notably, increased accumulation of lipid metabolites in skeletal muscle is observed both in endurance exercise—associated with improved insulin sensitivity—and in high-fat diets that induce insulin resistance. The review examines the contrasting metabolic adaptations of skeletal muscle to these opposing conditions and highlights the key signaling molecules involved. The focus then shifts to the role of the stress kinase p38α mitogen-activated protein kinase (MAPK) in skeletal muscle adaptation to overnutrition and endurance exercise. p38α enhances mitochondrial oxidative capacity and regulates nutrient utilization, both critical for maintaining metabolic homeostasis. During exercise, it cooperates with AMP-activated protein kinase (AMPK) to boost glucose uptake and fatty acid oxidation, key mechanisms for improving insulin sensitivity. The co-activation of p38α and AMPK in skeletal muscle emerges as a promising therapeutic avenue to combat insulin resistance and T2D. The review explores strategies for selectively enhancing p38α activity in skeletal muscle. In conclusion, it advocates a comprehensive approach to T2D prevention and treatment, combining established caloric intake-reducing therapies, such as GLP-1 receptor agonists, with interventions aimed at increasing energy expenditure via activation of p38α and AMPK signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, The Ruth and Bruce Rappaport Faculty of Medicine, P.O. Box 9649, Bat Galim, Haifa 31096, Israel.
Förderung
- Rappaport Family Institute for Research in the Medical Sciences
Zitieren
APA
Bengal, E., & Aviram, S. (2025). p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes. Cells, 14(16), 1277. https://doi.org/10.3390/cells14161277
Vancouver
Bengal E, Aviram S. p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes. Cells. 2025;14(16):1277. doi:10.3390/cells14161277
BibTeX
@article{Bengal2025,
author = {Bengal, Eyal and Aviram, Sharon},
title = {p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes},
journal = {Cells},
year = {2025},
volume = {14},
number = {16},
pages = {1277},
doi = {10.3390/cells14161277}
}
EUVIMED